Berkley W R Corp Acquires 534,533 Shares of GP-Act III Acquisition Corp. $GPAT

Berkley W R Corp boosted its stake in shares of GP-Act III Acquisition Corp. (NASDAQ:GPAT) by 171.2% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 846,823 shares of the company’s stock after purchasing an additional 534,533 shares during the period. Berkley W R Corp’s holdings in GP-Act III Acquisition were worth $9,180,000 at the end of the most recent quarter.

Several other hedge funds have also bought and sold shares of GPAT. Bank of America Corp DE bought a new position in shares of GP-Act III Acquisition in the third quarter worth approximately $85,000. Cannon Global Investment Management LLC raised its position in shares of GP-Act III Acquisition by 38.1% during the 4th quarter. Cannon Global Investment Management LLC now owns 14,500 shares of the company’s stock valued at $155,000 after purchasing an additional 4,000 shares during the period. Schonfeld Strategic Advisors LLC purchased a new position in shares of GP-Act III Acquisition during the 3rd quarter valued at $203,000. Lineage Point Capital LP purchased a new position in shares of GP-Act III Acquisition during the 4th quarter valued at $695,000. Finally, Shaolin Capital Management LLC bought a new position in GP-Act III Acquisition in the 2nd quarter worth $1,055,000.

Analyst Ratings Changes

Separately, Weiss Ratings reiterated a “sell (d)” rating on shares of GP-Act III Acquisition in a research note on Friday, July 17th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, GP-Act III Acquisition has a consensus rating of “Sell”.

GP-Act III Acquisition Stock Performance

Shares of GPAT opened at $11.05 on Monday. The company’s fifty day moving average is $10.95 and its 200 day moving average is $10.85. GP-Act III Acquisition Corp. has a fifty-two week low of $10.50 and a fifty-two week high of $12.00.

GP-Act III Acquisition (NASDAQ:GPAT) last announced its quarterly earnings results on Thursday, May 14th. The company reported $0.06 EPS for the quarter.

GP-Act III Acquisition Company Profile

GP-Act III Acquisition Corp is a special purpose acquisition company organized as a Delaware corporation that completed its initial public offering in 2021. As a blank-check company, it has no commercial operations of its own and was formed to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

The company’s primary business activity is to identify and acquire a target company in sectors such as technology, business services, healthcare or other high-growth industries.